These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6671134)

  • 21. Blood colony-forming cells (CFU-C) and leucocyte colony-stimulating activity (CSA) in patients with neutrophilic leucocytosis.
    Morra L; Ponassi A; Gigli G; Vercelli M; Sacchetti C
    Scand J Haematol; 1979 Apr; 22(4):311-6. PubMed ID: 472655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro sensitivity of accessory hematopoietic cells from neutropenic subjects to the activity of human gamma-globulin].
    Ghizzi A; De Caro L
    Boll Soc Ital Biol Sper; 1993 Sep; 69(9):549-56. PubMed ID: 7512346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil peripheral count and human leukocyte elastase during chronic lithium carbonate therapy.
    Capodicasa E; Russano AM; Ciurnella E; De Bellis F; Rossi R; Scuteri A; Biondi R
    Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):671-83. PubMed ID: 11105780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y; Harada M; Teshima T; Makino S; Inaba S; Akashi K; Shibuya T; Niho Y
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
    Alegre A; Tomás JF; Martínez-Chamorro C; Gil-Fernández JJ; Fernández-Villalta MJ; Arranz R; Díaz MA; Granda A; Bernardo MR; Escudero A; López-Lorenzo JL; Fernández-Rañada JM
    Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CFU-GM inhibitors in neutropenia.
    Morris TC; Vincent PC; Young GA; Sutherland R; Forrest PR; Irvine AE; Isbister JP
    Clin Lab Haematol; 1989; 11(1):31-45. PubMed ID: 2706902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
    Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
    Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability.
    Balint B; Ivanović Z; Petakov M; Taseski J; Jovcić G; Stojanović N; Milenković P
    Bone Marrow Transplant; 1999 Mar; 23(6):613-9. PubMed ID: 10217193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
    Glaser M
    Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
    Mahendra P; Johnson D; Scott MA; Jestice HK; Hood IM; Ager S; Bass G; Barker P; Boraks PA; Bloxham DM; Baglin TP; Marcus RE
    Bone Marrow Transplant; 1996 Apr; 17(4):503-7. PubMed ID: 8722346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
    Stewart AK; Imrie K; Keating A; Anania S; Nayar R; Sutherland DR
    Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
    Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
    Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.